Flucindole
 | |
| Clinical data | |
|---|---|
| Other names | WIN-35150; WIN35150; WIN-35,150 |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H16F2N2 |
| Molar mass | 250.293 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Flucindole (INN, USAN; developmental code name WIN-35150) is an antipsychotic with a tricyclic and tryptamine-like structure that was never marketed.[1][2] It is the 6,8-difluoro derivative of ciclindole.[3] The drug is about 5 to 10 times more potent than ciclindole both in vitro and in vivo.[2]
See also
[edit]References
[edit]- ^ Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 556. ISBN 978-1-4757-2085-3. Retrieved 2 November 2024.
- ^ a b Wood PL, McQuade PS (1984). "Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 8 (4–6): 773–7. doi:10.1016/0278-5846(84)90057-5. PMID 6152347. S2CID 39252411.
- ^ Edelson J, Benziger DP (1980). "Disposition of a series of tetrahydrocarbazoles". Drug Metabolism Reviews. 11 (2): 263–89. doi:10.3109/03602538008994027. PMID 7011760.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |